Making Leukemia Tumor Cells Sensitive Again, with the Help of Antibiotics (1 of 2) (IMAGE)
Caption
Microscopic images showing leukemia cells treated with venetoclax alone (Ven), tedizolid alone (Ted), or both venetoclax and tedizolid for four days. This material relates to a paper that appeared in the Oct. 30, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by D. Sharon at Princess Margaret Cancer Centre, Toronto in Toronto, ON, Canada; and colleagues was titled, "Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response."
Credit
D. Sharon <i>et al., Science Translational Medicine</i> (2019)
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content